Serum cystatin C level in patients with rheumatoid arthritis after single infusion of infliximab.
Kopec-Medrek
M
M
Widuchowska
M
M
Kotulska
A
A
Zycinska-Dębska
E
E
Kucharz
E J
EJ
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy*; D055316:Cystatin C / Q000097:blood*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D055316:Cystatin C; D000069285:Infliximab; D011241:Prednisone; D008727:Methotrexate